A retrospective study of the prevalence of herpes simplex virus and herpes zoster virus infection
Abstract
Introduction: Herpes simplex virus (HSV) and herpes zoster virus (HZV) are two members of the herpes virus family that can manifest in oral mucosa. Following primary infection, the viruses remain latent and may reactivate if the immune system becomes compromised. The purpose of this study was to know the prevalence and the site of manifestation of HSV and HZV infection in RSUP Hasan Sadikin Bandung from January 2007 until December 2011. Method: The method of this study was descriptive retrospective using secondary data and literature study. Data were taken from medical records of patients in RSUP Hasan Sadikin Bandung, from January 2007 until December 2011. The results were then presented in table and graphs. Result: The study’s result showed the prevalence of HSV infection from 2007-2011 was 6% while the prevalence of HZV infection was 46%. HSV and HZV infection occurred 41% at head and neck, 36% at trunk, 13% at extremities, 7% generalized, and 3% unspecified. The systemic diseases involved in these herpes viruses found in 20.3% patients. Conclusion: The conclusion of this study were the prevalence of HSV infection was low, while the prevalence of HZV infection was high. HSV infection frequently affected at head and neck, and HZV infection frequently affected the trunk. Systemic diseases involved in these herpes viruses were malignancies, neoplasm, internal organ disorders, skin diseases, blood disorder, and nerve disorder.
Keywords
Full Text:
PDFReferences
Neville B, Damm DD, Allen CM, Bouquot J. Oral and Maxillofacial Pathology. 3rd ed. Saunders. Noida. 2009. p. 240-48.
Greenberg MS, Glick M. Burket’s Oral Medicine: Diagnosis and Treatment. 10th ed. BC Decker Inc. Ontario. 2003. p. 51-57, 67-68, 75-76.
Sapp JP, Eversole LR, Wysocki GP. Contemporary Oral and Maxillofacial Pathology. 2nd ed. Missouri Mosby. Ontario. 2004. p. 269-272.
Howard M, Sellors JW, Jang D, Robinson NJ, Fearon M, Kaczorowski J et al. Regional distribution of antibodies to herpes simplex virus type 1 (HSV-1) and HSV-2 in men and women in Ontario, Canada. J Clinical Microbiology 2003;41(1):84-9.
Cunningham, A.L.; Taylor, R.; Taylor, J.; Marks, C.; Shaw, J.; and Mindel, A. 2005. Prevalence of infection with herpes simplex virus types 1 and 2 in Australia: a nationwide population based survey. J. of STI 82: 164-168.
Abdul Latheef EN1, Pavithran K. Herpes zoster: a clinical study in 205 patients. Indian J Dermatol. 2011 Sep-Oct;56(5):529-32.
Cowan F, Copas A, Johnson A, Ashley R, Corey, L, Mindel A. Herpes simplex virus type 1 infection: A sexually transmitted infection of adolescence? Sex Transm Infect. 2002 Oct; 78(5):346–8.
Cowan F, French R, Mayaud P, Gopal R, Robinson NJ, Oliveira SA et al. Seroepidemiological study of herpes simplex virus types 1 and 2 in Brazil, Estonia, India, Morocco, and Sri Lanka. Sex Transm Infect. 2003 Aug; 79(4): 286–290.
Tseng HF, Smith N, Harpaz R, Bialek SR, Sy LS, Jacobsen SJ. Herpes zoster vaccine in older adults and the risk of subsequent herpes zoster disease. JAMA 2011;305(2):212-4.
Vyse AJ, Gay NJ, Slomka MJ, Gopal R, Gibbs T, Morgan-Capner P, Brown DW. The burden of infection with HSV-1 and HSV-2 in England and Wales: implications for the changing epidemiology of genital herpes. Sex Transm Infect. 2000 Jun;76(3):183-7.
Rajendran R, Sivapathasundharam B. Shafer’s Textbook of Oral Pathology. 6th ed. Elsevier. Noida. 2009. p. 333-9, 344-47.
Wolff K, Goldsmith LA, Katz SI, Gilchrest BA, Paller AS, Leffell DJ. Fitzpatrick’s Dermatology in General Medicine. 7th ed. McGraw Hill. New York. 2008. p. 1873-98.
Douglas G, Couch RB. A prospective study of chronic herpes simplex virus infection and recurrent herpes labialis in humans. J Immunol. 1970 Feb;104(2):289-95.
Gnann JW, Whitley R. Herpes zoster. N Eng J Med. 2002;347(5):340-6.
DOI: https://doi.org/10.24198/pjd.vol26no2.26695
Refbacks
- There are currently no refbacks.
Visitor Stat
Padjadjaran Journal of Dentistry is licensed under Creative Commons Attribution 4.0 International License